Viewing Study NCT01865292


Ignite Creation Date: 2025-12-24 @ 3:42 PM
Ignite Modification Date: 2026-04-18 @ 5:14 PM
Study NCT ID: NCT01865292
Status: COMPLETED
Last Update Posted: 2015-10-19
First Post: 2013-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NN5401-1719
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators